"Never doubt that a small group of thoughtful, committed citizens can change the world. Indeed, it is the only thing that ever has."

Margaret Mead
Original article
peer-reviewed

Correction: Ivermectin Prophylaxis Used for COVID-19: A Citywide, Prospective, Observational Study of 223,128 Subjects Using Propensity Score Matching



Correction

It has come to the attention of the journal that several authors failed to disclose all relevant conflicts of interest when submitting this article. As a result, Cureus is issuing the following erratum and updating the relevant conflict of interest disclosures to ensure these conflicts of interest are properly described as recommended by the ICMJ:

  • Lucy Kerr: Paid consultant for both Vitamedic, an ivermectin manufacturer, and Médicos Pela Vida (MPV), an organization that promotes ivermectin as a treatment for COVID-19.
  • Flavio A. Cadegiani: Paid consultant ($1,600.00 USD) for Vitamedic, an ivermectin manufacturer. Dr. Cadegiani is a founding member of the Front Line COVID-19 Critical Care Alliance (FLCCC), an organization that promotes ivermectin as a treatment for COVID-19.
  • Pierre Kory: President and Chief Medical Officer of the Front Line COVID-19 Critical Care Alliance (FLCCC), an organization that promotes ivermectin as a treatment for COVID-19. Dr. Kory reports receiving payments from FLCCC. In February of 2022, Dr. Kory opened a private telehealth fee-based service to evaluate and treat patients with acute COVID, long haul COVID, and post-vaccination syndromes.
  • Jennifer A. Hibberd: Co-founder of the Canadian Covid Care Alliance and World Council for Health, both of which discourage vaccination and encourage ivermectin as a treatment for COVID-19.
  • Juan J. Chamie-Quintero: Contributor to the Front Line COVID-19 Critical Care Alliance (FLCCC) and lists the FLCCC as his employer on his LinkedIn page.
Original article
peer-reviewed

Correction: Ivermectin Prophylaxis Used for COVID-19: A Citywide, Prospective, Observational Study of 223,128 Subjects Using Propensity Score Matching


Author Information

Lucy Kerr

Medicine, Instituto Kerr, São Paulo, BRA

Flavio A. Cadegiani Corresponding Author

Clinical Endocrinology, Corpometria Institute, Brasilia, BRA

Fernando Baldi

Animal Sciences, Universidade Estadual de São Paulo (UNESP), São Paulo, BRA

Raysildo B. Lobo

Genetics, Universidade de São Paulo, Ribeirão Preto, BRA

Washington Luiz O. Assagra

Genetics, Centro Técnico de Avaliação Genômica - C.T.A.G., Ribeirão Preto, BRA

Fernando Carlos Proença

Bioinformatics, Itajaí City Hall, Itajaí, BRA

Pierre Kory

Internal Medicine, Front Line COVID-19 Critical Care Alliance (FLCCC), Madison, USA

Jennifer A. Hibberd

Dentistry, University of Toronto, Toronto, CAN

Juan J. Chamie-Quintero

Data Analysis, Universidad EAFIT, Medellín, COL


PDF Share